Interview: Ahmed Zaghloul – President, Egypt Otsuka
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Egypt Otsuka was established in 10th of Ramadan City in 1992 aiming to supply Otsuka’s pharmaceutical products in the Egyptian market and succeeded to the business of Arab Otsuka Pharmaceutical Co., S.A.E. established in the Public Free Zone (special tax free zone for export) in Cairo in 1977. Since then, Egypt Otsuka has been engaged in manufacturing and distributing intravenous infusions and therapeutic drugs in Egypt and neighbouring countries in the Middle East as well as in Africa. Along with growing demands for intravenous infusion products in those markets, Egypt Otsuka’s production capacity has nearly reached a maximum level and its expansion has been an immediate task to meet the growing demand.
In June of 2014, acquired 80% of Ateco Pharma Egypt, an Egyptian intravenous infusion manufacturing company and has a large domestic market share. This acquisition enabled Egypt Otsuka to expand its annual production capacity of intravenous infusions by approximately 50% in volume and sufficiently meet the increasing demands in the market. Ateco Pharma Egypt was renamed as “Otsuka Ateco Pharma Egypt” following the acquisition.
Contact
ar El-Sadik St, off Dr. Abdallah El-Araby street (Tayaran), Nasr City, 11759 Cairo
Phone: 20 201 536 9561
Fax: 20 201 536 9564
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Dr Sherif Rashed, managing partner and chairman of Magicpharma, explains how the company’s unique business model has allowed it to become one of the Top 50 pharmaceutical companies in Egypt…
Dr Wafik Bardissi, chairman and CEO of Minapharm, the only company to offer biosimilars in Egypt, highlights how the company has successfully developed biotech know-how by partnering with and acquiring…
Dr Mohamed Mabrouk, CEO of Pharmed Healthcare, highlights how the company has evolved from only offering Hepatitis C treatment to having 112 products in the pipeline today. He also emphasises…
Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships…
Ahmed Elfangary, country manager of DHL Express Egypt, highlights the company’s leadership position in the Egyptian logistics field, while aiming to be a strong partner of the government. He also…
The 100 Million Seha (100 Million healthy lives) campaign, which kicked off on a national scale in October 2018 under the auspices of President Abdel Fattah El-Sisi, aims to detect…
Amro Kandil, managing director of Northeast Africa at GE Healthcare, emphasizes the company’s crucial role in improving healthcare in Egypt as part of a long-standing partnership with the Ministry of…
Ramez Mohsen, managing director at Janssen for Egypt, Jordan, Libya & Sudan, highlights how the company is driving real access to treatments in Egypt through collaboration with various stakeholders. He…
Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an…
Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political…
Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both…
Christelle Saghbini, the newly appointed chairman & managing director of Sanofi for Egypt & Sudan, highlights her strategic roadmap for bringing access to innovative medicines to Egypt. She also explains…
See our Cookie Privacy Policy Here
